The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 3,066 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 412 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 421 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
ANTARES PHARMA INC | COM | 036642106 | 1,350 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CARDINAL HEALTH INC | COM | 14149Y108 | 1,174 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,458 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 3,160 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 3,764 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GREENLANE HLDGS INC | CL A | 395330103 | 560 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 3,565 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 1,489 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
MODERNA INC | COM | 60770K107 | 708 | 10,000 | SH | Put | SOLE | 10,000 | 0 | 0 | |
NOVAVAX INC | COM NEW | 670002401 | 542 | 5,000 | SH | Put | SOLE | 5,000 | 0 | 0 | |
PROSHARES TR | ULTRAPRO SHORT S | 74347B268 | 2,175 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PROSHARES TR | ULTRAPRO SHORT S | 74347B268 | 870 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
PROSHARES TR II | VIX SH TRM FUTRS | 74347W171 | 510 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
TYME TECHNOLOGIES INC | COM | 90238J103 | 2,132 | 2,175,000 | SH | SOLE | 2,175,000 | 0 | 0 | ||
VYNE THERAPEUTICS INC | COM NEW | 92941V100 | 2,988 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 |